Study details
Enrolling now
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
Medical College of Wisconsin
NCT IDNCT06228599ClinicalTrials.gov data as of Apr 2026
Target enrollment
40
Study length
about 2.4 years
Ages
18+
Locations
1 site in WI
What this study is about
This trial is testing a treatment plan for pancreatic cancer patients who have had surgery and are at high risk of the cancer coming back. The goal is to see if this personalized therapy helps prevent or delay recurrence.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Treatment Plan
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Adverse Events, Disease-free Survival
Body systems
Oncology